Pegaptanib Sodium Compared to Sham Injection in Patients With DME Involving the Center of the Macula
Status:
Completed
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether pegaptanib sodium (Macugen) is safe and
effective in slowing the leakage of fluid within the retina and thereby stabilizing or
improving vision when compared to placebo injections. A total of 176 patients will be
enrolled